|
1
|
Neal CS, Michael MZ, Rawlings LH, Van der
Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs
in renal cancer. BMC Med. 8:642010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rasmussen F: Metastatic renal cell cancer.
Cancer Imaging. 13:374–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rini BI, Rathmell WK and Godley P: Renal
cell carcinoma. Curr Opin Oncol. 20:300–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao X, Zhao Z, Xu W, Hou J and Du X:
Down-regulation of miR-497 is associated with poor prognosis in
renal cancer. Int J Clin Exp Pathol. 8:758–764. 2015.PubMed/NCBI
|
|
6
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang J, Yao X, Zhang J, Dong B, Chen Q,
Xue W, Liu D and Huang Y: Hypoxia-induced downregulation of miR-30c
promotes epithelial-mesenchymal transition in human renal cell
carcinoma. Cancer Sci. 104:1609–1617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo Z, Zhang L, Li Z, Jiang C, Dai Y, Liu
X, Zheng Y, Yu H, Xiang J and Li G: miR-149 promotes
epithelial-mesenchymal transition and invasion in nasopharyngeal
carcinoma cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 36:604–609.
2011.PubMed/NCBI
|
|
9
|
Cai Y, Li H and Zhang Y: Downregulation of
microRNA-206 suppresses clear cell renal carcinoma proliferation
and invasion by targeting vascular endothelial growth factor A.
Oncol Rep. 35:1778–1786. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Duan L, Guo T, Gao Y, Tian L, Liu
J, Wang S and Yang J: Downregulation of miR-30c promotes renal
fibrosis by target CTGF in diabetic nephropathy. J Diabetes
Complications. 30:406–414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Y, Zhu J, Lei Z, Wan L, Zhu X, Ye F and
Tong Y: Expression and functional role of miR-29b in renal cell
carcinoma. Int J Clin Exp Pathol. 8:14161–14170. 2015.PubMed/NCBI
|
|
12
|
Tang K and Xu H: Prognostic value of
meta-signature miRNAs in renal cell carcinoma: An integrated miRNA
expression profiling analysis. Sci Rep. 5:102722015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakada C, Matsuura K, Tsukamoto Y,
Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida
T, Sato F, et al: Genome-wide microRNA expression profiling in
renal cell carcinoma: Significant down-regulation of miR-141 and
miR-200c. J Pathol. 216:418–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyoshi K, Miyoshi T and Siomi H: Many
ways to generate microRNA-like small RNAs: Non-canonical pathways
for microRNA production. Mol Genet Genomics. 284:95–103. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Denby L and Baker AH: Targeting non-coding
RNA for the therapy of renal disease. Curr Opin Pharmacol.
27:70–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li M, Wang Y, Song Y, Bu R, Yin B, Fei X,
Guo Q and Wu B: MicroRNAs in renal cell carcinoma: A systematic
review of clinical implications (Review). Oncol Rep. 33:1571–1578.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang X, Huang M, Kong L and Li Y: miR-372
suppresses tumour proliferation and invasion by targeting IGF2BP1
in renal cell carcinoma. Cell prolif. 48:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XJ, Hong Q, Wang Z, Yu YY, Zou X and
Xu LH: MicroRNA21 promotes interstitial fibrosis via targeting
DDAH1: A potential role in renal fibrosis. Mol Cell Biochem.
411:181–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su Z, Chen D, Zhang E, Li Y, Yu Z, Shi M,
Jiang Z, Ni L, Yang S, Gui Y, et al: MicroRNA-509-3p inhibits
cancer cell proliferation and migration by targeting the
mitogen-activated protein kinase kinase kinase 8 oncogene in renal
cell carcinoma. Mol Med Rep. 12:1535–1543. 2015.PubMed/NCBI
|
|
22
|
Song T, Zhang X, Wang C, Wu Y, Cai W, Gao
J and Hong B: MiR-138 suppresses expression of hypoxia-inducible
factor 1α (HIF-1α) in clear cell renal cell carcinoma 786-O cells.
Asian Pac J Cancer Prev. 12:1307–1311. 2011.PubMed/NCBI
|
|
23
|
Kawakami K, Enokida H, Chiyomaru T,
Tatarano S, Yoshino H, Kagara I, Gotanda T, Tachiwada T, Nishiyama
K, Nohata N, et al: The functional significance of miR-1 and
miR-133a in renal cell carcinoma. Eur J Cancer. 48:827–836. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishikawa R, Chiyomaru T, Enokida H,
Inoguchi S, Ishihara T, Matsushita R, Goto Y, Fukumoto I, Nakagawa
M and Seki N: Tumour-suppressive microRNA-29s directly regulate
LOXL2 expression and inhibit cancer cell migration and invasion in
renal cell carcinoma. FEBS Lett. 589:2136–2145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wotschofsky Z, Busch J, Jung M,
Kempkensteffen C, Weikert S, Schaser KD, Melcher I, Kilic E, Miller
K, Kristiansen G, et al: Diagnostic and prognostic potential of
differentially expressed miRNAs between metastatic and
non-metastatic renal cell carcinoma at the time of nephrectomy.
Clin Chim Acta. 416:5–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stark MS, Bonazzi VF, Boyle GM, Palmer JM,
Symmons J, Lanagan CM, Schmidt CW, Herington AC, Ballotti R,
Pollock PM and Hayward NK: miR-514a regulates the tumour suppressor
NF1 and modulates BRAFi sensitivity in melanoma. Oncotarget.
6:17753–17763. 2015. View Article : Google Scholar : PubMed/NCBI
|
